Late Onset Hypogonadism (LOH) and sexual Health
|
|
Dr. Jacques Buvat |
It is well established that there is an age-related decline in testosterone production of men, which might play a role in the age-related decline in sexual desire and erections. Such a causal relationship is still debated since few studies found significant relationships between serum testosterone and sexual parameters of aging men that persist after adjustment of the data for age. In addition although 2 meta-analyses of randomized controlled trials confirmed a significant effect of testosterone therapy on sexual desire and erections of men of any age when baseline testosterone is below 12 nmol/l, the effect of this therapy is rather disappointing when it is used in the specific and prevalent population of the men presenting with erectile dysfunction (ED), and who are subsequently diagnosed with LOH.
Several causes may account for this lower success rate: the threshold level of the testosterone activity on sexual desire and erections may be as low as 7 nmol/l in some men. In addition, in men with ED and LOH vascular comorbidities are prevalent and may prevent the effect of testosterone therapy on erections. Lastly the hypogonadism associated with ED may be in some cases a consequence rather than the cause of ED. Even if testosterone therapy may fail to improve erectile function of some hypogonadal ED patients, routine testosterone determination remains mandatory in aging men consulting for ED. Achieving physiologic levels of testosterone is indeed one of the rare opportunities to restore spontaneous erections and save the patient from having to plan sexual activity. In addition restoring testosterone, which is generally low in such patients, is the only way of restoring sexual desire. Replacing testosterone may also improve other symptoms associated with LOH. Lastly a threshold testosterone level appears to be required to achieve full efficacy with PDE5 inhibitors in certain men, although this hypothesis has still to be confirmed.
Conflict of Interest: None disclosed Financial Support/Funding: None disclosed Recorded: Sydney, Australia, April 2007
|
Jacques Buvat
other talks by the speaker
|

Dr. Jacques Buvat
|
Dr. Jacques Buvat has been the director of the Centre d'Etude et de Traitement de la Pathologie de l'Appareil Reproducteur et de la Psychosomatique (CETPARP) in Lille, France since 1974. The center's research focuses on sexual dysfunctions, especially erectile dysfunction, infertility and in vitro fertilization, and endocrinology in gynecology and andrology.
Dr. Buvat is a member of editorial boards for the International Journal of Impotence Research, Archivio Italiano Nephrologia And rologia, Andrologie and Gynécologie Obstétrique Fertilité. He is also the chief editor of bulletins for the International Society for Sexual and Impotence Research and the French Société de Médecine de la Reproduction.
Active in the International Society for Sexual and Impotence Research since 1985, Dr. Buvat is currently the president-elect after having been secretary general and treasurer from 1996 to 2000. From 1991 to 1993, Dr. Buvat served as president of the French Speaking Society of Andrology and also directed the series "Progress In Andrology." He is a member of numerous professional societies, including the European Society for Impotence Research and has written more than 300 scientific papers or chapters in books.
Dr. Buvat is also the president of the Association pour l'Etude et le Traitement de la Pathologie de l'Appareil Reproducteur et de la Psychomatique, and of the Association pour le Développement de l'Information et de la Recherche sur la Sexualité (ADIRS), a non profit organisation dedicated to informing the public on sexuality and sexual problems. ADIRS is the French chapter of the European Sexual Dysfunction Alliance (ESDA).
|

Navigation
......................................
......................................
......................................
|
Help
......................................
......................................
......................................
|
Audio Visual Archives
......................................
......................................
......................................
|
Useful
......................................
......................................
......................................
|
|
|
|